Current perspectives of enteric fever: A hospital-based study from India

Annals of Tropical Paediatrics

Volumn 25, Issue 3, 2005, Pages 161-174

  Walia, Mandeep ^a   Gaind, Rajni ^a,c   Mehta, Rajesh ^a   Paul, Premila ^a   Aggarwal, Pushpa ^a   Kalaivani, Mani ^b  

^a SAFDARJUNG HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFIXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TYPHOID VACCINE;

CHILD HEALTH; DISEASE INCIDENCE; DRUG RESISTANCE; EPIDEMIOLOGY;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASCITES; BACTERIUM ISOLATION; BLOOD CULTURE; BRAIN DISEASE; CHILD; CHILDHOOD MORTALITY; CLINICAL FEATURE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HEPATITIS; HUMAN; HYPOTENSION; INCIDENCE; INDIA; INFANT; INTESTINE PERFORATION; JAUNDICE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PERITONITIS; PLEURA EFFUSION; PNEUMONIA; RETROSPECTIVE STUDY; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SEASONAL VARIATION; TREATMENT OUTCOME; TYPHOID FEVER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; INDIA; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; RETROSPECTIVE STUDIES; RISK FACTORS; SALMONELLA PARATYPHI A; SALMONELLA TYPHI; SEASONS; SEROTYPING; SEX DISTRIBUTION; TYPHOID FEVER;

SALMONELLA; SALMONELLA PARATYPHI; SALMONELLA TYPHI;

EID: 23944526544     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1179/146532805X58085     Document Type: Article

References (42)

1. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull WHO 2004; 82:346-53.
2. Ferreccio C, Levine MM, Manterola A, et al. Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 years. J Pediatr 1984; 106:899-901.
3. Butler T, Islam A, Kabir I, Jones PK. Patterns of morbidity and mortality in typhoid fever dependent on age and gender: a review of 552 hospitalized patients with diarrhea. Rev Infect Dis 1991; 13:85-90.
4. Brooks WA, Hossain A, Goswami D, et al. Bacteremic typhoid fever in children in an urban slum, Bangladesh. Emerg Infect Dis 2005; 11:326-9.
5. Murdoch DA, Banatvaia N, Bone A, Shoismatulloev BI, Ward LR, Threlfall EJ. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet 1998; 351:339.
6. Threlfall EJ, Ward LR. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis 2001; 7:448-50.
7. Ackers ML, Puhr ND, Tauxe RV, Mintz ED. Laboratory based surveillance of Salmonella serotype typhi infections in United States: antimicrobial resistance on the rise. JAMA 2000; 283:2668-73.
8. Bhutta ZA, Farooqui BJ, Sturm AW. Eradication of a multiple drug resistant Salmonella paratyphi A causing meningitis with ciprofloxacin. J Infect 1992; 25:215-19.
9. Saha SK, Talukder SY, Islam M, Saha S. A highly ceftriaxone-resistant Salmonella typhi in Bangladesh. Pediatr Infect Dis J 1999; 18:387.
10. Ferraro MJ, Craig WA, Dudley MN, et al. Performance Standards for Antimicrobial Disk Susceptibility Tests, 7th edn. Wayne, PA: National Committee for Clinical Laboratory Standards, 2000.
11. Ferraro MJ, Craig WA, Dudley MN, et al. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 5th edn. Wayne, PA: National Committee for Clinical Laboratory Standards, 2000.
12. Braddick MR, Crump BJ, Yee ML. How long should patients with Salmonella typhi or Salmonella paratyphi be followed up? A comparison of published guidelines. J Pub Health Med 1991; 13:101-17.
13. Mahle WT, Levine MM. Salmonella typhi infection in children younger than five years of age. Pediatr Infect Dis J 1993; 12:627-31.
14. Sinha A, Sazawal S, Kumar R, et al. Typhoid fever in children aged less than 5 years. Lancet 1999; 354:734-7.
15. Saha SK, Baqui AH, Hanif M, et al. Typhoid fever in Bangladesh: implications for vaccination policy. Pediatr Infect Dis J 2001; 20:521-4.
16. Bhutta ZA, Naqvi SH, Razzaq RA, Farooqui BJ. Multidrug-resistant typhoid in children: presentation and clinical features. Rev Infect Dis 1991; 13:832-6.
17. Rodrigues C, Shenai S, Mehta A. Enteric fever in Mumbai, India: the good news and the bad news. Clin Infect Dis 2003; 36:535.
18. Padmapriya V, Kenneth J, Amarnath SK. Re-emergence of paratyphi A: a shift in immunity? Nad Med J India 2003; 16:47-8.
19. Chandel DS, Choudhary R, Dhawan B, Pandey A, Dey AB. Drug resistant Salmonella enterica serotype paratyphi A in India. Emerg Infect Dis 2000; 6:420-1.
20. Brown NM, Millar MR, Frost JA, Rowe B. Ciprofloxacin resistance in Salmonella paratyphi A. J Antimicrob Chemother 1994; 33:1258-9.
21. Mishra S, Patwari AK, Anand VK, et al. A clinical profile of multidrug resistant typhoid fever. Indian Pediatr 1991; 28:1171-4.
22. Thisyakorn U, Mansuwan P, Taylor DN. Typhoid and paratyphoid fever in 192 hospitalized children in Thailand. Am J Dis Child 1987; 141:862-5.
23. Van den Bergh ET, Gasem MH, Keuter M, Dolmans MV. Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990. Trop Med Int Health 1999; 4:211-15.
24. Khosla SN, Singh R, Singh GP, Trehan VK. The spectrum of hepatic injury in enteric fever. Am J Gastroenterol 1988; 83:413-16.
25. Mulligan TO. Typhoid fever in young children. Br Med J 1971; 4:665-7.
26. Bhutta ZA. Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child 1996; 75:214-17.
27. Hoa NTT, Diep TS, Wain J, et al. Community-acquired septicaemia in southern Viet Nam: the importance of multidrug-resistant Salmonella typhi. Trans R Soc Trop Med Hyg 1998; 92:503-8.
28. Rogerson SJ, Spooner VJ, Smith TA, Richens J. Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New Guinea. Trans R Soc Trop Med Hyg 1991; 85:113-16.
29. Hoffman SL, Punjabi NH, Kumala S, et al. Reduction of mortality in chloramphenicol treated severe typhoid fever by high dose dexamethasone. N Engl J Med 1984; 310:82-8.
30. Butler T, Knight J, Nath SK, Speelman P, Roy SK, Azad MA. Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management. Rev Infect Dis 1985; 7:244-56.
31. Sood S, Kapil A, Das B, Jain Y, Kabra SK. Re-emergence of chloramphenicol-sensitive Salmonella typhi. Lancet 1999; 353:1241-2.
32. Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35:1265-8.
33. Saha SK, Saha S, Ruhulamin M, Hanif M, Islam M. Decreasing trend of multiresistant Salmonella typhi in Bangladesh. J Antimicrob Chemother 1997; 39:554-6.
34. Wain J, Hoa NTT, Chinh NT, et al. Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997; 25:1404-10.
35. Hakanen A, Kotilainen P, Jalava J, Siitonen A, Huovinen P. Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 1999; 37:3572-7.
36. National Committee for Clinical and Laboratory Standards. Performance of standards of antimicrobial susceptibility testing: thirteenth informational supplement. NCCLS document M100-S13 (M7). Wayne, PA: NCCLS, 2003.
37. Helms M, Vastrup P, Gerner Smidt P, Molbak K. Excess mortality associated with antimicrobial drug resistant Salmonella typhimurium. Emerg Infect Dis 2002; 8:490-5.
38. Threlfall EJ, Ward LR, Skinner JA, Smith HR, Lacey S. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet 1999; 353:1590-1.
39. Dutta P, Mitra U, Datta S, et al. Ciprofloxacin susceptible Salmonella typhi with treatment failure. J Trop Pediatr 2001; 47:252-3.
40. Chandel DS, Chaudhry R. Enteric fever treatment failures: a global concern. Emerg Infect Dis 2001; 7:762-3.
41. Mehta G, Randhawa VS, Mohapatra NP. Intermediate susceptibility to ciprofloxacin in Salmonella typhi in India. Eur J Clin Microbiol Infect Dis 2001; 20:760-1.
42. Adachi T, Sagara H, Hirose K, Watanabe H. Fluoroquinolone resistant Salmonella paratyphi A. Emerg Infect Dis 2005; 11:172-4.